We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$881M
AUM Growth
-$121M
Cap. Flow
-$139M
Cap. Flow %
-15.77%
Top 10 Hldgs %
39.5%
Holding
4,106
New
974
Increased
850
Reduced
839
Closed
1,374

Sector Composition

Rank Sector Weight
1 Technology 2.15%
2 Energy 2.14%
3 Industrials 2.11%
4 Financials 2.11%
5 Consumer Discretionary 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGP
1951
DELISTED
GGP Inc.
GGP
$6K ﹤0.01%
236
-3,301
-93% -$76K
ORIG
1952
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
$6K ﹤0.01%
4
+2
+100% +$3.94K
RELY
1953
DELISTED
Real Industry, Inc.
RELY
$6K ﹤0.01%
2,191
-6,957
-76% -$19K
BKSC
1954
DELISTED
Bank of South Carolina
BKSC
$6K ﹤0.01%
+300
New +$5.49K
CBB
1955
DELISTED
Cincinnati Bell Inc.
CBB
$6K ﹤0.01%
300
-798
-73% -$14.3K
SGB
1956
DELISTED
Southwest Georgia Financial Corporation
SGB
$6K ﹤0.01%
300
+200
+200% +$4.1K
IPAS
1957
DELISTED
Ipass Inc Common Stock
IPAS
$6K ﹤0.01%
418
-261
-38% -$3.43K
RENX
1958
DELISTED
RELX N.V.
RENX
$6K ﹤0.01%
+298
New +$5.95K
SVA
1959
DELISTED
Sinovac Biotech, Ltd
SVA
$6K ﹤0.01%
+887
New +$4.86K
AAP icon
1960
Advance Auto Parts
AAP
$3.36B
$5K ﹤0.01%
46
-354
-89% -$48.6K
AC
1961
DELISTED
Associated Capital Group
AC
$5K ﹤0.01%
156
+35
+29% +$1.19K
ACTG icon
1962
Acacia Research
ACTG
$447M
$5K ﹤0.01%
1,200
+874
+268% +$4.07K
AES icon
1963
AES
AES
$10.5B
$5K ﹤0.01%
490
-1,535
-76% -$17.6K
APVO icon
1964
Aptevo Therapeutics
APVO
$4.92M
0
ARMK icon
1965
Aramark
ARMK
$14.9B
$5K ﹤0.01%
155
-657
-81% -$18K
BCBP icon
1966
BCB Bancorp
BCBP
$170M
$5K ﹤0.01%
338
-162
-32% -$2.54K
BRF icon
1967
VanEck Brazil Small-Cap ETF
BRF
$22M
$5K ﹤0.01%
238
-25
-10% -$494
CIG icon
1968
CEMIG Preferred Shares
CIG
$6.24B
$5K ﹤0.01%
4,394
-33,710
-88% -$44.7K
CNXN icon
1969
PC Connection
CNXN
$2.16B
$5K ﹤0.01%
+171
New +$4.71K
CRBP icon
1970
Corbus Pharmaceuticals
CRBP
$165M
$5K ﹤0.01%
+27
New +$5.29K
DAC icon
1971
Danaos Corp
DAC
$2.59B
$5K ﹤0.01%
195
+156
+400% +$3.39K
DLHC icon
1972
DLH Holdings
DLHC
$72.8M
$5K ﹤0.01%
+1,019
New +$5.27K
DXR icon
1973
Daxor
DXR
$63.3M
$5K ﹤0.01%
733
+58
+9% +$401
ELDN icon
1974
Eledon Pharmaceuticals
ELDN
$265M
$5K ﹤0.01%
44
-123
-74% -$12.5K
EPR icon
1975
EPR Properties
EPR
$4.69B
$5K ﹤0.01%
+71
New +$5.17K

Similar funds

Tower Research Capital (TRC)'s Q2 2017 Portfolio in Review

As of Q2 2017, Tower Research Capital (TRC) held 4,106 positions worth $881M, down 12% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tower Research Capital (TRC) withdrew a net $139M in Q2 2017, closing 1,374 positions and reducing 839 holdings. Its most notable exit was State Street SPDR S&P Retail ETF, an estimated $5.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.5% a quarter earlier, followed by Energy and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $17.2M.

  • Tower Research Capital (TRC)'s largest Q2 2017 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 382,942 shares worth $17.2M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $60M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $152M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P Retail ETF in Q2 2017, selling an estimated $5.29M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 40% of its $881M portfolio in Q2 2017.
  • Tower Research Capital (TRC) opened 974 new positions and closed 1,374 in Q2 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 12% quarter-over-quarter to $881M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.